Latest DCTD News and Announcements

Recent News

Schedule of DCTD Presentations at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

• May 19, 2026

NCI-supported Breast Cancer De-escalation Trial Exceeds Accrual Expectations

• May 12, 2026

NCI Alliance for Nanotechnology in Cancer: 2026 Annual Principal Investigator (PI) Meeting

• April 29, 2026

NCI Publishes Updated Best Practices for Biospecimen Resources

• April 21, 2026

Powering Cancer Research: How The Cancer Imaging Archive (TCIA) Is Evolving to Support the Next Generation of Discovery

• April 16, 2026

Schedule of DCTD Presentations at the 2026 American Association for Cancer Research Annual Meeting

• March 23, 2026

NCI Releases Updated Version of the Common Terminology Criteria for Adverse Events (CTCAE) Reporting in Clinical Trials

• March 18, 2026

Proteogenomic Analysis Provides Molecular Insights In Gallbladder Cancer

• March 4, 2026

CPTAC Collaborates with Beat Childhood Cancer Research Consortium at Penn State to Advance Pediatric Oncology

• February 20, 2026

ComboMATCH Clinical Trial Protocol Updates Enhance Patient Care

• February 17, 2026

Multiomic Profiling Identifies High-Risk Markers in Pancreatic Precursors

• February 13, 2026

Proteomics Provides Insights Into DNA-PK Inhibitor Mechanism in Patient Samples

• January 20, 2026

Featuring CPTAC Investigators: Sara Gosline, Ph.D.

• January 8, 2026